Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Viral Recombination

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.

Human Virome

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Transmission of Pathogens

Transmission of Pathogens

Pathogens spread from their reservoirs to susceptible hosts through three main routes: contact transmission, vehicle transmission, and vector transmission. Each route involves distinct mechanisms of transfer.Contact TransmissionThis category includes direct contact, indirect contact, and droplet transmission:Direct contact involves immediate physical interaction between individuals—such as a handshake—which can spread pathogens like Streptococcus pyogenes, the bacterium responsible for...

Respiratory Syncytial Virus Disease

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of Sofosbuvir (β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine) as an inhibitor of Dengue virus replication<sup/>.

Scientific reports·2017

Same author

Monotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized mice.

The Journal of antimicrobial chemotherapy·2017

Same author

HIV drug resistance against strand transfer integrase inhibitors.

Retrovirology·2017

Same author

HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters.

The Journal of antimicrobial chemotherapy·2017

Same author

Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region.

Vaccine·2017

Same author

The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration.

mBio·2017

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus

Published on: October 7, 2011

XMRV as a human pathogen?

Mark A Wainberg¹, Kuan-Teh Jeang

¹McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, Canada.

Cell Host & Microbe

|April 20, 2011

Summary

This summary is machine-generated.

Xenotropic murine leukemia virus-related virus (XMRV) was investigated for its link to prostate cancer and chronic fatigue syndrome (CFS). Recent findings suggest XMRV is not an authentic human pathogen, challenging previous associations.

More Related Videos

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

Related Experiment Videos

Last Updated: Jun 2, 2026

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus

Published on: October 7, 2011

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

Area of Science:

Virology
Oncology
Immunology

Background:

Xenotropic murine leukemia virus-related virus (XMRV) has been controversially linked to prostate cancer and chronic fatigue syndrome (CFS).
Replication failures by multiple research groups have cast doubt on the initial findings.
The scientific community requires a clear understanding of XMRV's role in human disease.

Purpose of the Study:

To critically evaluate the evidence for XMRV as a human pathogen.
To address the conflicting reports regarding XMRV's association with specific diseases.
To provide a conclusive perspective on the authenticity of XMRV in human infections.

Main Methods:

Review of existing scientific literature and replication studies.
Analysis of data from independent investigations into XMRV.
Comparative assessment of positive and negative findings.

Main Results:

Multiple independent studies have failed to detect XMRV in patients with prostate cancer or CFS.
Evidence suggests that initial positive findings may have resulted from laboratory contamination.
The prevalence of XMRV in the human population appears to be negligible.

Conclusions:

XMRV is unlikely to be an authentic human pathogen.
The proposed associations between XMRV and prostate cancer or CFS are not supported by robust scientific evidence.
Further research should focus on validated etiological agents for these conditions.